Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD45RO Antibody (190-2F2.5), Allophycocyanin/Cy7, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP247956APCCY7
Description
CD45RO Monoclonal specifically detects CD45RO in Human samples. It is validated for Flow Cytometry.Specifications
CD45RO | |
Monoclonal | |
APC-Cyanine7 | |
PBS with 0.05% Sodium Azide | |
PTPRC | |
Lentillectin purified glycoproteins obtained from HuPBL and from a CLL (B cell). | |
0.1 mL | |
Primary | |
Recognizes a 180-185kDa protein, identified as isoform of leukocyte common antigen (CD45RO). This antibody reacts with mature activated T-cells, most thymocytes, and a sub-population of resting T-cells within both CD4 and CD8 subsets. It shows no reactivity with normal B or natural killer cells, but reacts with granulocytes and monocytes. Reportedly, it is useful to identify T-cell lymphomas and leukemias. It rarely stains NK cells or B-cell lymphomas. | |
Store at 4°C in the dark. Do not freeze. |
Flow Cytometry | |
190-2F2.5 | |
Flow Cytometry | |
B220, CD45 antigen, CD45R, EC 3.1.3.48, L-CA, LY5, protein tyrosine phosphatase, receptor type, C, receptor-type tyrosine-protein phosphatase C, T200 glycoprotein, T200 leukocyte common antigen, T200receptor type, c polypeptide | |
Mouse | |
Protein A or G purified | |
Adaptive Immunity, Cell Biology, Cellular Markers, Cellular Signaling, Cytokine Research, Glia Markers, Hematopoietic Stem Cell Markers, Immunology, Immunophenotyping, MAP Kinase Signaling, Mast Cell Markers, Mesenchymal Stem Cell Markers, Microglia Markers, Modulation of DNA Pools, Myeloid Cell Markers, Myeloid derived Suppressor Cell, Neurodegeneration, Neuronal Cell Markers, Neuroscience, Signal Transduction, Stem Cell Markers | |
5788.0 | |
Human | |
IgG2a κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction